Dogwood Therapeutics, Inc. - Common Stock, $0.0001 par value (DWTX)
CUSIP: 92829J203
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 29,716,833
- Total 13F shares
- 120
- Share change
- 0
- Total reported value
- $253
- Price per share
- $2.11
- Number of holders
- 1
Quarterly Holders Quick Answers
What is CUSIP 92829J203?
CUSIP 92829J203 identifies DWTX - Dogwood Therapeutics, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 92829J203:
Top shareholders of DWTX - Dogwood Therapeutics, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Sealbond Ltd |
13D/G
3/4/5
|
CK Life Sciences Int'l., (Holdings) Inc. · Director, Other*, 10%+ Owner |
83%
|
24,664,971
|
$164,022,057 | +$162,616,360 | 21 Nov 2025 | |
| William Pridgen |
3/4/5
|
Director |
—
mixed-class rows
|
764,196
mixed-class rows
|
$992,479 | — | 26 Feb 2024 | |
| Orca Capital AG |
13D/G
|
— |
3.7%
|
69,821
|
$390,299 | -$256,967 | 14 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.1%
|
29,955
|
$124,613 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
16,779
|
$69,805 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.04%
|
11,655
|
$48,485 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
9,415
|
$39,167 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,748
|
$7,272 | — | 31 Dec 2025 | |
| CK Life Sciences Intl (Holdings) Inc |
3/4/5
|
Director, Other*, 10%+ Owner |
—
class O/S missing
|
284
|
$1,993 | — | 12 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
477
|
$1,984 | — | 31 Dec 2025 | |
| Activest Wealth Management |
13F
|
Company |
0%
|
120
|
$499 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0%
|
30
|
$125 | — | 31 Dec 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
9
|
$37 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
2
|
$8 | — | 31 Dec 2025 | |
| Gregory Scott Duncan |
3/4/5
|
CHIEF EXECUTIVE OFFICER, Director |
—
class O/S missing
|
330,000
|
— | — | 05 Mar 2026 | |
| Angela Walsh |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
82,500
|
— | — | 05 Mar 2026 | |
| Ralph Grosswald |
3/4/5
|
SVP OF OPERATIONS |
—
class O/S missing
|
82,500
|
— | — | 05 Mar 2026 | |
| Roger Michael Gendreau |
3/4/5
|
CHIEF MEDICAL OFFICER |
—
class O/S missing
|
82,500
|
— | — | 05 Mar 2026 | |
| Richard Alan Burch |
3/4/5
|
Director |
—
class O/S missing
|
2,917
|
— | — | 26 Feb 2024 | |
| Abel de la Rosa |
3/4/5
|
Director |
—
class O/S missing
|
2,362
|
— | — | 27 Jun 2025 | |
| David R. Keefer |
3/4/5
|
Director |
—
class O/S missing
|
2,362
|
— | — | 27 Jun 2025 | |
| John C. Thomas |
3/4/5
|
Director |
—
class O/S missing
|
2,362
|
— | — | 27 Jun 2025 | |
| Richard James Whitley |
3/4/5
|
Director |
—
class O/S missing
|
2,362
|
— | — | 27 Jun 2025 |
Institutional Holders of Dogwood Therapeutics, Inc. - Common Stock, $0.0001 par value (DWTX) as of Q1 2026
As of 31 Mar 2026,
Dogwood Therapeutics, Inc. - Common Stock, $0.0001 par value (DWTX) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
120 shares.
The largest 1 holders included
Activest Wealth Management.
This page lists
1
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
10
Q1 2026 holders
1
Holder diff
-9
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.